SOCS7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.484000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.641800E-01
Normal-vs-Stage2
6.655400E-01
Normal-vs-Stage3
2.071200E-01
Normal-vs-Stage4
6.011800E-01
Stage1-vs-Stage2
1.817950E-02
Stage1-vs-Stage3
7.738400E-02
Stage1-vs-Stage4
7.675800E-01
Stage2-vs-Stage3
2.246400E-01
Stage2-vs-Stage4
1.492390E-01
Stage3-vs-Stage4
8.848500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.801800E-01
Normal-vs-AfricanAmerican
7.963000E-01
Normal-vs-Asian
1.155760E-01
Caucasian-vs-AfricanAmerican
5.507800E-01
Caucasian-vs-Asian
5.878500E-03
AfricanAmerican-vs-Asian
3.294400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.136800E-01
Normal-vs-Female
9.797400E-01
Male-vs-Female
2.856200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.691000E-01
Normal-vs-Age(41-60Yrs)
9.224600E-01
Normal-vs-Age(61-80Yrs)
7.233600E-01
Normal-vs-Age(81-100Yrs)
4.670200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.026600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.082800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.025000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.738020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.051800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.069600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.735000E-01
Normal-vs-Daily Drinker
3.006800E-01
Normal-vs-Weekly Drinker
4.145000E-01
Normal-vs-Occasional Drinker
9.424600E-01
Normal-vs-Social Drinker
6.125200E-01
Non Drinker-vs-Daily Drinker
7.466800E-01
Non Drinker-vs-Weekly Drinker
7.045200E-01
Non Drinker-vs-Occasional Drinker
1.678030E-01
Non Drinker-vs-Social Drinker
6.772500E-02
Daily Drinker-vs-Weekly Drinker
5.656800E-01
Daily Drinker-vs-Occasional Drinker
1.217830E-01
Daily Drinker-vs-Social Drinker
5.805700E-02
Weekly Drinker-vs-Occasional Drinker
3.348600E-01
Weekly Drinker-vs-Social Drinker
9.317700E-02
Occasional Drinker-vs-Social Drinker
2.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.076600E-01
Normal-vs-Grade 2
9.355800E-02
Normal-vs-Grade 3
6.641900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.154400E-02
Grade 1-vs-Grade 3
3.173200E-01
Grade 1-vs-Grade 4
2.076600E-01
Grade 2-vs-Grade 3
9.695800E-02
Grade 2-vs-Grade 4
9.355800E-02
Grade 3-vs-Grade 4
6.641900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.696200E-01
Normal-vs-NonDiabetic
7.704000E-01
Diabetic-vs-NonDiabetic
3.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.112000E-01
Normal-vs-NoPancreatitis
7.642000E-01
Pancreatitis-vs-NoPancreatitis
6.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.711400E-01
Normal-vs-N1
7.172200E-01
N0-vs-N1
5.006400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.939400E-01
Normal-vs-TP53-NonMutant
7.971600E-01
TP53-Mutant-vs-TP53-NonMutant
5.440800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
